215 related articles for article (PubMed ID: 23303745)
21. New Psychoactive Substances 3-Methoxyphencyclidine (3-MeO-PCP) and 3-Methoxyrolicyclidine (3-MeO-PCPy): Metabolic Fate Elucidated with Rat Urine and Human Liver Preparations and their Detectability in Urine by GC-MS, "LC-(High Resolution)-MSn" and "LC-(High Resolution)-MS/MS".
A Michely JA; Manier SK; Caspar AT; Brandt SD; Wallach J; Maurer HH
Curr Neuropharmacol; 2017; 15(5):692-712. PubMed ID: 27758707
[TBL] [Abstract][Full Text] [Related]
22. Designer drugs 2,5-dimethoxy-4-bromo-amphetamine (DOB) and 2,5-dimethoxy-4-bromo-methamphetamine (MDOB): studies on their metabolism and toxicological detection in rat urine using gas chromatographic/mass spectrometric techniques.
Ewald AH; Fritschi G; Bork WR; Maurer HH
J Mass Spectrom; 2006 Apr; 41(4):487-98. PubMed ID: 16470568
[TBL] [Abstract][Full Text] [Related]
23. Elucidation of the metabolites of the novel psychoactive substance 4-methyl-N-ethyl-cathinone (4-MEC) in human urine and pooled liver microsomes by GC-MS and LC-HR-MS/MS techniques and of its detectability by GC-MS or LC-MS(n) standard screening approaches.
Helfer AG; Turcant A; Boels D; Ferec S; Lelièvre B; Welter J; Meyer MR; Maurer HH
Drug Test Anal; 2015 May; 7(5):368-75. PubMed ID: 24953431
[TBL] [Abstract][Full Text] [Related]
24. The in vivo and in vitro metabolism and the detectability in urine of 3',4'-methylenedioxy-alpha-pyrrolidinobutyrophenone (MDPBP), a new pyrrolidinophenone-type designer drug, studied by GC-MS and LC-MS(n.).
Meyer MR; Mauer S; Meyer GM; Dinger J; Klein B; Westphal F; Maurer HH
Drug Test Anal; 2014; 6(7-8):746-56. PubMed ID: 24124065
[TBL] [Abstract][Full Text] [Related]
25. New designer drug 1-(3-trifluoromethylphenyl) piperazine (TFMPP): gas chromatography/mass spectrometry and liquid chromatography/mass spectrometry studies on its phase I and II metabolism and on its toxicological detection in rat urine.
Staack RF; Fritschi G; Maurer HH
J Mass Spectrom; 2003 Sep; 38(9):971-81. PubMed ID: 14505325
[TBL] [Abstract][Full Text] [Related]
26. Studies on the metabolism and detectability of the emerging drug of abuse diphenyl-2-pyrrolidinemethanol (D2PM) in rat urine using GC-MS and LC-HR-MS/MS.
Meyer MR; Schmitt S; Maurer HH
J Mass Spectrom; 2013 Feb; 48(2):243-9. PubMed ID: 23378097
[TBL] [Abstract][Full Text] [Related]
27. New designer drugs N-(1-phenylcyclohexyl)-2-ethoxyethanamine (PCEEA) and N-(1-phenylcyclohexyl)-2-methoxyethanamine (PCMEA): Studies on their metabolism and toxicological detection in rat urine using gas chromatographic/mass spectrometric techniques.
Sauer C; Peters FT; Staack RF; Fritschi G; Maurer HH
J Mass Spectrom; 2008 Mar; 43(3):305-16. PubMed ID: 17968862
[TBL] [Abstract][Full Text] [Related]
28. Biotransformation and detectability of the designer drug 2,5-dimethoxy-4-propylphenethylamine (2C-P) studied in urine by GC-MS, LC-MS(n), and LC-high-resolution-MS(n).
Wink CS; Meyer MR; Braun T; Turcant A; Maurer HH
Anal Bioanal Chem; 2015 Jan; 407(3):831-43. PubMed ID: 25120185
[TBL] [Abstract][Full Text] [Related]
29. Metabolic fate, mass spectral fragmentation, detectability, and differentiation in urine of the benzofuran designer drugs 6-APB and 6-MAPB in comparison to their 5-isomers using GC-MS and LC-(HR)-MS(n) techniques.
Welter J; Brandt SD; Kavanagh P; Meyer MR; Maurer HH
Anal Bioanal Chem; 2015 May; 407(12):3457-70. PubMed ID: 25711990
[TBL] [Abstract][Full Text] [Related]
30. Metabolic fate and detectability of the new psychoactive substances 2-(4-bromo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25B-NBOMe) and 2-(4-chloro-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25C-NBOMe) in human and rat urine by GC-MS, LC-MS
Caspar AT; Brandt SD; Stoever AE; Meyer MR; Maurer HH
J Pharm Biomed Anal; 2017 Feb; 134():158-169. PubMed ID: 27915193
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of Glaucine Content in Bulgarian Black Sea Coast Localities of Glauciumflavum Cranz. (Papaveraceae).
Doycheva I; Philipov S; Stanilova M
Nat Prod Commun; 2017 Feb; 12(2):157-158. PubMed ID: 30428199
[TBL] [Abstract][Full Text] [Related]
32. Metabolism of the new psychoactive substances N,N-diallyltryptamine (DALT) and 5-methoxy-DALT and their detectability in urine by GC-MS, LC-MSn, and LC-HR-MS-MS.
Michely JA; Helfer AG; Brandt SD; Meyer MR; Maurer HH
Anal Bioanal Chem; 2015 Oct; 407(25):7831-42. PubMed ID: 26297461
[TBL] [Abstract][Full Text] [Related]
33. Metabolism and toxicological detection of the designer drug N-(1-phenylcyclohexyl)-3-methoxypropanamine (PCMPA) in rat urine using gas chromatography-mass spectrometry.
Sauer C; Peters FT; Staack RF; Fritschi G; Maurer HH
Forensic Sci Int; 2008 Oct; 181(1-3):47-51. PubMed ID: 18922655
[TBL] [Abstract][Full Text] [Related]
34. Gas and liquid chromatography-mass spectrometry studies on the metabolism of the synthetic phenylacetylindole cannabimimetic JWH-250, the psychoactive component of smoking mixtures.
Grigoryev A; Melnik A; Savchuk S; Simonov A; Rozhanets V
J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Sep; 879(25):2519-26. PubMed ID: 21803006
[TBL] [Abstract][Full Text] [Related]
35. Diphenidine, a new psychoactive substance: metabolic fate elucidated with rat urine and human liver preparations and detectability in urine using GC-MS, LC-MS
Wink CS; Michely JA; Jacobsen-Bauer A; Zapp J; Maurer HH
Drug Test Anal; 2016 Oct; 8(10):1005-1014. PubMed ID: 26811026
[TBL] [Abstract][Full Text] [Related]
36. Dimethocaine, a synthetic cocaine analogue: studies on its in-vivo metabolism and its detectability in urine by means of a rat model and liquid chromatography-linear ion-trap (high-resolution) mass spectrometry.
Meyer MR; Lindauer C; Welter J; Maurer HH
Anal Bioanal Chem; 2014 Mar; 406(7):1845-54. PubMed ID: 24448968
[TBL] [Abstract][Full Text] [Related]
37. New designer drug, 2,5-dimethoxy-4-propylthio-beta-phenethylamine (2C-T-7): studies on its metabolism and toxicological detection in rat urine using gas chromatography/mass spectrometry.
Theobald DS; Fehn S; Maurer HH
J Mass Spectrom; 2005 Jan; 40(1):105-16. PubMed ID: 15643651
[TBL] [Abstract][Full Text] [Related]
38. New designer drug 1-(3,4-methylenedioxybenzyl) piperazine (MDBP): studies on its metabolism and toxicological detection in rat urine using gas chromatography/mass spectrometry.
Staack RF; Maurer HH
J Mass Spectrom; 2004 Mar; 39(3):255-61. PubMed ID: 15039932
[TBL] [Abstract][Full Text] [Related]
39. Studies on the metabolism and toxicological detection of the new designer drug 4'-methyl-alpha-pyrrolidinobutyrophenone (MPBP) in rat urine using gas chromatography-mass spectrometry.
Peters FT; Meyer MR; Fritschi G; Maurer HH
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Sep; 824(1-2):81-91. PubMed ID: 16046201
[TBL] [Abstract][Full Text] [Related]
40. Gas chromatography/negative ion chemical ionization mass spectrometry and liquid chromatography/electrospray ionization tandem mass spectrometry quantitative profiling of N-acetylcysteine conjugates of valproic acid in urine: application in drug metabolism studies in humans.
Gopaul SV; Farrell K; Abbott FS
J Mass Spectrom; 2000 Jun; 35(6):698-704. PubMed ID: 10862121
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
